Is ¹⁸F Fluorodeoxyglucose Positron Emission Tomography Useful to Assess Activity of Myositis?

REFERENCES

1. 1.↵
   1. Owada T,
   2. Maezawa R,
   3. Kurasawa K,
   4. Okada H,
   5. Arai S,
   6. Fukuda T

   . Detection of inflammatory lesions by F-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J Rheumatol 2012;39:1659–65.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Pipitone N,
   2. Versari A,
   3. Zuccoli G,
   4. Levrini G,
   5. Macchioni P,
   6. Bajocchi G,
   7. et al.

   18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: A case series. Clin Exp Rheumatol 2012;30:570–3.

   OpenUrlPubMed
3. 3.↵
   1. Walter MA,
   2. Melzer RA,
   3. Schindler C,
   4. Muller-Brand J,
   5. Tyndall A,
   6. Nitzsche EU

   . The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005;32:674–81.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Harari OA,
   2. Al-Nahhas A,
   3. Jawad A

   . 18F-fluorodeoxyglucose-positron emission tomography imaging in idiopathic inflammatory myositis. Nucl Med Commun 2008;29:838–40.

   OpenUrlPubMed
5. 5.↵
   1. Loe MJ,
   2. Subramaniam RM,
   3. Kalra S,
   4. Tiegs RD,
   5. Mullan BP,
   6. Utz JP

   . Interesting image. F-18 fluorodeoxyglocose positron emission tomography/computed tomography in the diagnosis of chronic myopathic sarcoidosis. Clin Nucl Med 2010;35:22–3.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Troyanov Y,
   2. Targoff IN,
   3. Tremblay JL,
   4. Goulet JR,
   5. Raymond Y,
   6. Senecal JL

   . Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: Analysis of 100 French Canadian patients. Medicine 2005;84:231–49.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Marie I

   . Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 2012;14:275–85.

   OpenUrlCrossRefPubMed